MeiraGTx Holdings (MGTX) Cash & Equivalents (2017 - 2025)
MeiraGTx Holdings posted quarterly Cash & Equivalents of $65.9 million for Q4 2025, down 36.4% year-on-year from $103.7 million in Q4 2024, and up 344.25% on a QoQ basis from $14.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Cash & Equivalents data on file, last reported at $65.9 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Equivalents fell 36.4% year-over-year to $65.9 million; the trailing twelve-month figure through Dec 2025 stood at $65.9 million (down 36.4% YoY), and the FY2025 full-year result was $65.9 million, down 36.4% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $65.9 million, up from $14.8 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $199.4 million in Q1 2021 and bottomed at $14.8 million in Q3 2025.
- The 5-year median for Cash & Equivalents is $108.7 million (2022), against an average of $102.8 million.
- The widest annual swing landed in 2024, when Cash & Equivalents surged 94.14%; it then sank 88.13% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $137.7 million in 2021, then decreased by 16.11% to $115.5 million in 2022, then rose by 13.1% to $130.6 million in 2023, then dropped by 20.66% to $103.7 million in 2024, then tumbled by 36.4% to $65.9 million in 2025.
- The last three Cash & Equivalents figures came in at $65.9 million (Q4 2025), $14.8 million (Q3 2025), and $32.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.71 Bn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.93 Mn |
| Sep 30, 2025 | 14.84 Mn |
| Jun 30, 2025 | 32.17 Mn |
| Mar 31, 2025 | 66.52 Mn |
| Dec 31, 2024 | 103.66 Mn |
| Sep 30, 2024 | 125.03 Mn |
| Jun 30, 2024 | 101.03 Mn |
| Mar 31, 2024 | 120.27 Mn |
| Dec 31, 2023 | 130.65 Mn |
| Sep 30, 2023 | 64.40 Mn |
| Jun 30, 2023 | 92.77 Mn |
| Mar 31, 2023 | 68.78 Mn |
| Dec 31, 2022 | 115.52 Mn |
| Sep 30, 2022 | 114.71 Mn |
| Jun 30, 2022 | 72.11 Mn |
| Mar 31, 2022 | 113.78 Mn |
| Dec 31, 2021 | 137.70 Mn |
| Sep 30, 2021 | 143.63 Mn |
| Jun 30, 2021 | 172.56 Mn |
| Mar 31, 2021 | 199.41 Mn |
| Dec 31, 2020 | 209.52 Mn |
| Sep 30, 2020 | 179.33 Mn |
| Jun 30, 2020 | 194.81 Mn |
| Mar 31, 2020 | 210.41 Mn |
| Dec 31, 2019 | 227.23 Mn |
| Sep 30, 2019 | 253.45 Mn |
| Jun 30, 2019 | 204.40 Mn |
| Mar 31, 2019 | 227.40 Mn |
| Dec 31, 2018 | 68.20 Mn |
| Sep 30, 2018 | 88.68 Mn |
| Jun 30, 2018 | 102.18 Mn |
| Mar 31, 2018 | 32.48 Mn |
| Dec 31, 2017 | 8.67 Mn |
| Sep 30, 2017 | 5.42 Mn |
| Jun 30, 2017 | 5.33 Mn |